Brief: Egetis Gets Positive CHMP Opinion For Emcitate For MCT8 Deficiency Treatment

Egetis Therapeutics AB (publ)

12/12/2024 14:43

Dec 12 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS RECEIVES POSITIVE CHMP OPINION FOR EMCITATE®
(TIRATRICOL)
FOR THE TREATMENT OF MCT8 DEFICIENCY

Source text:  ID:nMFN95yrF7 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))